Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Short Interest Update

Basilea Pharmaceutica AG (OTCMKTS:BPMUF) saw a significant decline in short interest in the month of December. As of December 15th, there was short interest totalling 25,000 shares, a decline of 11.0% from the November 30th total of 28,100 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

Basilea Pharmaceutica Price Performance

OTCMKTS BPMUF remained flat at $52.83 during trading hours on Monday. Basilea Pharmaceutica has a 1 year low of $38.60 and a 1 year high of $52.83. The company has a 50 day moving average price of $52.83 and a 200-day moving average price of $50.67.

Analysts Set New Price Targets

Separately, HC Wainwright upgraded shares of Basilea Pharmaceutica to a “strong-buy” rating in a research report on Monday, September 23rd.

Basilea Pharmaceutica Company Profile

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.